|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|PE Ratio (TTM)||86.83|
|Earnings Date||Dec 14, 2017 - Dec 15, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Jacksonville, FL, July 09, 2018 (GLOBE NEWSWIRE) -- mCig, Inc. (MCIG), a diversified company servicing the legal cannabis markets, announced today an update for its HEMP project and new line of CBD products, soon to be hitting the markets. “With different company divisions getting a traction and starting to show a real growth we finally decided to jump start our CBD division with an introduction of a new line of hemp products, that will include natural skin cosmetics, full spectrum tinctures and probiotic pets edibles.
JACKSONVILLE, FL, June 20, 2018-- mCig, Inc., a leading distributor of innovative products, customized packaging solutions, technologies, and services for the global medical cannabis industry, announced ...
The potential to become wealthy often means investing in an enterprise when it is small and waiting for the entity to grow large. For this reason, many investors are willing to take chances on what they believe to be hot penny stocks.
Jacksonville, FL., June 07, 2018 (GLOBE NEWSWIRE) -- mCig Inc., (MCIG), a leading provider of technologies and solutions for the legal medical and recreational marijuana industry, is pleased to provide an update on its 40-acre industrial hemp project in New York. This spring, NYAcres propagated 80,000 industrial hemp seeds with FarmOn! Foundation in Copake NY projecting 55,000 pounds of processable flower for CBD extraction to sell as an ingredient for white label products demanding hemp oil and promoting its benefits. Since sprouting seeds NYAcres is currently planting 40 acres of industrial hemp outdoors in certified organic fields focused on two varieties of CBD concentrated organic seed strains: Cherry Wine, and Berry Blossom, which yield 12-15 percent CBD concentration.
JACKSONVILLE, FL, May 31, 2018 (GLOBE NEWSWIRE) -- mCig, Inc. (MCIG) www.mciggroup.com, a diversified company servicing the legal cannabis markets, is pleased to announce they have closed escrow on the purchase of a 2.5 acre parcel in California City, CA. Located half way between the Los Angeles and Sequoia National Forests, the property is ideal for growing and cultivation.
Expanding Operations and Services to California and Colorado. JACKSONVILLE, FL, May 22, 2018-- mCig, Inc., a leading distributor of innovative products, technologies, and services for the global medical ...
JACKSONVILLE, FL, April 30, 2018 (GLOBE NEWSWIRE) -- mCig, Inc. (OTCBB: MCIG) www.mciggroup.com, a diversified company servicing the legal cannabis markets, announced today that it has officially been awarded three licenses from California City, California, for recreational cannabis cultivation, statewide distribution, and manufacturing. The extremely competitive licensing procedure of California City took in over 300 applications, awarding only 16 licenses at this time, 3 of which belong to MCIG. The property will be developed into a state-of-the-art 30,000 square foot “Smart Greenhouse” cultivation facility by the company’s construction subsidiary, Grow Contractors, Inc. In addition, it has been planned out to have a 2,000 square foot manufacturing facility to create extracts, and a small distribution center that will be used to move products to retailers. This facility is projected, when fully operating, to generate approximately $20M in annual income.
On April 11, Bloomberg reported that Boehner joined the advisory board of Acreage Holdings, a cannabis dispensary and cultivation company. Marijuana legalization was never a popular topic among Republicans, and even Democrats have historically punted on the issue.
According to data published by Energias Market Research, the global medical cannabis market is anticipated to grow significantly from USD 8.28 billion in 2017 to USD 28.07 billion by 2024 and at a CAGR of 19.1% over the forecast period. Factors driving the growth of the legal cannabis industry include mounting recognition of medical benefits, growing demand for cannabis in the treatment of various diseases, and increasing number of research and development activities. In the U.S, there are 28 states that have approved the use of cannabis for medical purposes.
NEW YORK, NY / ACCESSWIRE / February 26, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of MassRoots, Inc. (OTCQB: MSRT) and Mcig, Inc. (OTCQB: MCIG), including ...